During the past decade, Guerbet LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guerbet LLC" are "Cerebral Arterial Diseases" (2 trials), "Renal Artery Stenosis" (1 trials) and "Renal Disease" (1 trials). Many other conditions were trialed in "Guerbet LLC" in a lesser frequency.

Most popular intervention types in "Guerbet LLC" are "Drug" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dotarem" (3 trials), "TOF MRA" (2 trials), "Gadoterate meglumine (Dotarem)" (1 trials), "Time of Flight" (1 trials) and "Time of Flight Magnetic Resonance Angiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guerbet LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Guerbet LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Guerbet LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Guerbet LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".